BOUCHERVILLE, QC, Feb. 3, 2026 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (The "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced today that it has granted an aggregate of 960,000 stock options ("Options") to its non-executive directors and to certain executives and employees, as part of their compensation. The Options have an exercise price of CAD $0.52 per share and are exercisable for a period of ten-(10) years from the date of grant. Options granted to non-executive directors vest immediately as of the date of grant while Options to executives and employees vest over three (3) years. The Options were granted in accordance with the Corporation's Stock Option Plan.
Read more at newswire.ca
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
LSL PHARMA GROUP GRANTS STOCK OPTIONS
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
